The global Pharmaceutical Suppositories market size was valued at US$ 1.44 billion in 2020, with a compound annual growth rate of 5.9% from 2021 to 2028.
Report coverage
| Market |
Pharmaceutical Suppositories Market |
| Analysis Period |
2017 - 2028 |
| Base Year |
2020 |
| Forecast Data |
2021 - 2028 |
| Segments Covered |
By Type, By Base, By End-User, By Distribution Channel, and By Geography |
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
Bayer AG, Bliss GVS Pharma Ltd, Cadila Healthcare Ltd, Church And Dwight Uk Ltd, Cosette Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Novartis International Ag, Pfizer Inc., and Sanofi S.A. among others.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
| Customization Scope |
10 hrs of free customization and expert consultation
|
A pharmaceutical suppository is a medication delivery technique that is inserted into the rectum, vagina, or urethra that dissolves or melts, allowing the medicine to be absorbed into the bloodstream. It is a small round or cone-shaped object that is inserted into a body. Suppositories make it easier for a person to take medicine that can’t be swallowed or that stomach or intestines wouldn’t absorb. For some past years, pharmaceutical suppositories are in high demand as they tend to work quickly. This is because the suppositories melt inside the body and are absorbed directly into the bloodstream. They're utilized to deliver drugs that operate both locally and systemically. Some are placed in the rectum, while others are placed in the vagina. Urethral suppositories are, however, less commonly used. According to research, taking drugs through the rectum creates a rather stable environment in which a drug can be delivered. However, absorption rates may be lower than for medications taken by mouth.
Pharmaceutical Suppositories Market Dynamics
The growing elderly population worldwide is the major consumer base for pharmaceutical suppositories. This is the primary factor that is driving the expansion of the global pharmaceutical suppositories market. According to the World Population Ageing stats, there were 727 million people aged 65 years or over in 2020. Moreover, the elderly population globally is projected to more than double, reaching over 1.5 billion in 2050. Elderly people usually cannot intake medication by mouth, also their digestive system is sensitive which makes them reluctant to take medicine by mouth. Thus, the elderly population is the primary reason for the growing demand for pharmaceutical suppositories' market share.
Medical suppositories are also advised to young ones by healthcare professionals as they often suffer from problems like constipation, vomiting, and stomachache. Reluctance towards high-powered dosage is also another factor that is contributing towards the high pharma suppositories market growth. Additionally, some of the worldwide pharmaceutical suppositories market trends are that they avoid the first-pass effect, melt at body temperature, could be given to unconscious patients, and are useful for rapid and direct effect in the rectum.
However, several stringent regulations imposed by the international governments in the industry are holding the market to grow at a slow pace. Then again, lack of awareness in developing countries and a social stigma tagged to suppositories are also creating a negative impact in the industry thus, limiting the global pharmaceutical suppositories market size. The suppository has to go through some strict approval guidelines to be launched into the market. Controlling the quality criteria of a dosage form in its final state is required by pharmaceutical standards. To release its active components, the entire suppository is melted in an independently tempered wet measurement unit to control particle size. Furthermore, advancement in medication coupled with growing research & development activities is expected to propel the market growth with some attractive business opportunities in the coming years.
Growing elderly population throughout the world
According to the World Health Organization (WHO), one out of every six persons on the planet will be 60 years old or older by 2030. The number of people aged 60 and more is expected to rise from 1 billion in 2020 to 1.4 billion by 2050. Between 2020 and 2050, the number of people aged 80 and more is predicted to treble, reaching 426 million. Population aging occurs in tandem with greater social and economic changes occurring around the world. Similarly, the organization states that the population is aging at a considerably higher rate than in the past. Therefore, the growing elderly population fuels the growth of the suppositories market, and according to the statistics; the market is going to enjoy substantial growth in the coming decades.
Global Pharmaceutical Suppositories Market Segmentation
The global pharmaceutical suppositories market is segmented based on type, base, distribution channel, end-user, and region. Based on the types segment, the market classifies as vaginal suppositories, rectal suppositories, and urethral suppositories. Among types, the rectal suppositories were the most demanded segment category in 2020. The high growth in the segment is credited to the growing emphasis on the development of rectal suppositories. Vaginal suppositories are anticipated to register significant growth during the forecast period.
By base, the segmentation bifurcates into the water-miscible base (soap glycerin suppositories, polyethylene glycol bases, and glycero gelatin base), fatty bases, and emulsifying bases (Massa esterium, witepsol, and massuppol). The emulsifying bases lead the base segment with maximum share in 2020 as they solidify rapidly, are nonirritant, and are less liable to get rancid. The distribution channel segment is further categorized into retail pharmacies, hospital pharmacies, and online sales. Among them, hospital pharmacies acquired the largest shares in 2020, while the online sales channel segment is expected to witness the fastest growth during the forecast timeframe from 2021 to 2028. Moreover, the end-user segment is further sub-segmented into hospitals & clinics, nursing homes, and home care. Where the hospitals & clinics segment generated the highest revenue in the year 2020 because of the increasing inclination of hospitals towards pharmaceutical suppositories to instantly treat pediatric or geriatric patients.
Global Pharmaceutical Suppositories Regional Overview
North America region is expected to lead the global market during the forecasted years from 2021 to 2028
Among all the geography, North America produced the highest revenues in 2020 and continues to do so. This is attributed to the presence of advanced healthcare facilities coupled with the presence of top pharma players in the region. However, the Asia-Pacific region is likely to register the highest CAGR throughout the forecast period due to the growing elderly population in countries such as China and India. Moreover, the rising cases of constipation and hemorrhoids in the region and growing investments in the healthcare & pharma industry propel the APAC pharmaceutical suppositories market growth.
Global Pharmaceutical Suppositories Competitive Landscape
This section of the report pinpoints various key vendors of the market. Some of the key players offered in the report include Bayer AG, Bliss GVS Pharma Ltd, Cadila Healthcare Ltd, Church And Dwight Uk Ltd, Cosette Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Novartis International Ag, Pfizer Inc., and Sanofi S.A. among others.
Market Segmentation
Market By Type
- Rectal Suppositories
- Vaginal Suppositories
- Urethral Suppositories
Market By Base
- Fatty Bases
- Emulsifying Bases
- Witepsol
- Massa Esterium
- Massuppol
- Water Miscible Base
- Glycero Gelatin Base
- Soap Glycerin Suppositories
- Polyethylene Glycol Bases
Market By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Sales
Market By End-User
- Hospitals & Clinics
- Home Care
- Nursing Home
Market By Geography
- North America
- Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Pharmaceutical Suppositories
1.1. Definition and Scope
1.1.1. Definition of Pharmaceutical Suppositories
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Pharmaceutical Suppositories market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Pharmaceutical Suppositories By Type
1.2.3. Pharmaceutical Suppositories By Base
1.2.4. Pharmaceutical Suppositories By Distribution Channel
1.2.5. Pharmaceutical Suppositories By End-User
1.2.6. Pharmaceutical Suppositories by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Pharmaceutical Suppositories Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Pharmaceutical Suppositories Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of Pharmaceutical Suppositories Major Manufacturers in 2019
CHAPTER 5. Pharmaceutical Suppositories By Type
5.1. Introduction
5.2. Pharmaceutical Suppositories Revenue By Type
5.2.1. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast, By Type, 2017-2028
5.2.2. Rectal Suppositories
5.2.2.1. Rectal Suppositories Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
5.2.3. Urethral Suppositories
5.2.3.1. Urethral Suppositories Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
5.2.4. Vaginal Suppositories
5.2.4.1. Vaginal Suppositories Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 6. Pharmaceutical Suppositories Market By Base
6.1. Introduction
6.2. Pharmaceutical Suppositories Revenue (US$ Bn) By Base
6.2.1. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
6.2.2. Fatty Bases
6.2.2.1. Fatty Bases Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.3. Emulsifying Bases
6.2.3.1. Emulsifying Based Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.3.2. Witepsol
6.2.3.2.1. Witepsol Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.3.3. Massa Esterium
6.2.3.3.1. Massa Esterium Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.3.4. Massuppol
6.2.3.4.1. Massuppol Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.4. Water Miscible Base
6.2.4.1. Water Miscible Base Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.4.2. Glycero Gelatin Base
6.2.4.2.1. Glycero Gelatin Base Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.4.3. Soap Glycerin Suppositories
6.2.4.3.1. Soap Glycerin Suppositories Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.4.4. Polyethylene Glycol Base
6.2.4.4.1. Polyethylene Glycol Base Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 7. Pharmaceutical Suppositories Market Revenue By End-User
7.1. Introduction
7.2. Pharmaceutical Suppositories Revenue (US$ Bn) By End-User
7.2.1. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
7.2.2. Hospitals & Clinics
7.2.2.1. Hospitals & Clinics Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
7.2.3. Home Care
7.2.3.1. Home Care Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
7.2.4. Nursing Home
7.2.4.1. Nursing Home Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 8. Pharmaceutical Suppositories Market By Distribution Channel
8.1. Introduction
8.2. Pharmaceutical Suppositories Revenue (US$ Bn) By Base
8.2.1. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
8.2.2. Retail Pharmacies
8.2.2.1. Retail Pharmacies Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
8.2.3. Hospital Pharmacies
8.2.3.1. Hospital Pharmacies Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
8.2.4. Nursing Home
8.2.4.1. Nursing Home Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 9. North America Pharmaceutical Suppositories Market By Country
9.1. North America Pharmaceutical Suppositories Overview
9.2. U.S.
9.2.1. U.S. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
9.2.2. U.S. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
9.2.3. U.S. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
9.2.4. U.S. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
9.3. Canada
9.3.1. Canada Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
9.3.2. Canada Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
9.3.3. Canada Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
9.3.4. Canada Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
9.4. North America PEST Analysis
CHAPTER 10. Europe Pharmaceutical Suppositories Market By Country
10.1. Europe Pharmaceutical Suppositories Overview
10.2. U.K.
10.2.1. U.K. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
10.2.2. U.K. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
10.2.3. U.K. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
10.2.4. U.K. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
10.3. Germany
10.3.1. Germany Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
10.3.2. Germany Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
10.3.3. Germany Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
10.3.4. Germany Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
10.4. France
10.4.1. France Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
10.4.2. France Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
10.4.3. France Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
10.4.4. France Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
10.5. Spain
10.5.1. Spain Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
10.5.2. Spain Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
10.5.3. Spain Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
10.5.4. Spain Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
10.6. Rest of Europe
10.6.1. Rest of Europe Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
10.6.2. Rest of Europe Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
10.6.3. Rest of Europe Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
10.6.4. Rest of Europe Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Pharmaceutical Suppositories Market By Country
11.1. Asia Pacific Pharmaceutical Suppositories Overview
11.2. China
11.2.1. China Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
11.2.2. China Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
11.2.3. China Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
11.2.4. China Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
11.3. Japan
11.3.1. Japan Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
11.3.2. Japan Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
11.3.3. Japan Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
11.3.4. Japan Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
11.4. India
11.4.1. India Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
11.4.2. India Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
11.4.3. India Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
11.4.4. India Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
11.5. Australia
11.5.1. Australia Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
11.5.2. Australia Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
11.5.3. Australia Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
11.5.4. Australia Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
11.6. South Korea
11.6.1. South Korea Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
11.6.2. South Korea Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
11.6.3. South Korea Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
11.6.4. South Korea Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
11.7.2. Rest of Asia-Pacific Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
11.7.3. Rest of Asia-Pacific Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
11.7.4. Rest of Asia-Pacific Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Pharmaceutical Suppositories Market By Country
12.1. Latin America Pharmaceutical Suppositories Overview
12.2. Brazil
12.2.1. Brazil Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
12.2.2. Brazil Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
12.2.3. Brazil Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
12.2.4. Brazil Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
12.3. Mexico
12.3.1. Mexico Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
12.3.2. Mexico Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
12.3.3. Mexico Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
12.3.4. Mexico Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
12.4. Rest of Latin America
12.4.1. Rest of Latin America Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
12.4.2. Rest of Latin America Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
12.4.3. Rest of Latin America Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
12.4.4. Rest of Latin America Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Pharmaceutical Suppositories Market By Country
13.1. Middle East & Africa Pharmaceutical Suppositories Overview
13.2. GCC
13.2.1. GCC Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
13.2.2. GCC Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
13.2.3. GCC Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
13.2.4. GCC Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
13.3. South Africa
13.3.1. South Africa Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
13.3.2. South Africa Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
13.3.3. South Africa Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
13.3.4. South Africa Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028
13.4.2. Rest of Middle East & Africa Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028
13.4.3. Rest of Middle East & Africa Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028
13.4.4. Rest of Middle East & Africa Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Pharmaceutical Suppositories
14.1. Pharmaceutical Suppositories Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Pharmaceutical Suppositories market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. COMPANY PROFILE
15.1. Bayer AG
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (US$ Bn), 2019
15.1.3.2. Bayer AG 2019 Pharmaceutical Suppositories Business Regional Distribution
15.1.4. Product/ Service and Specification
15.1.5. Recent Developments & Business Strategy
15.1.6. Manufacturing Plant Footprint Analysis
15.2. Bliss GVS Pharma Ltd
15.3. Cadila Healthcare Ltd
15.4. Church And Dwight Uk Ltd
15.5. Cosette Pharmaceuticals, Inc.
15.6. Glenmark Pharmaceuticals Limited
15.7. Intas Pharmaceuticals Ltd.
15.8. Novartis International Ag
15.9. Pfizer Inc.
15.10. Sanofi S.A.
15.11. Others
